Effects Of Saffron Supplementation On Inflammation And Metabolic Responses In Type 2 Diabetic Patients: A Randomized, Double-Blind, Placebo-Controlled Trial
Notes for this study:
||MDA (μM/L) Mean and SD. Placebo: before 15.8±2.7, after 15.9±2.7. Saffron: before 17.8±0.17, after 16.7±3.5
||Uncontrolled / observational study
|Number of Subjects
In a randomized, controlled trial, 90 participants with type 2 diabetes took 200 mg of saffron or placebo daily for 12 weeks.
There was a greater reduction in waist circumference in the saffron group, but the differences for body fat %, body weight, and BMI weren't statistically significant. There also weren't statistically significant differences for metabolic, lipid, or inflammatory markers. There was a greater reduction in malondialdehyde but not a significant difference in total antioxidant capacity.
The trial was preregistered: IRCT201510259472N9